“小糖丸”是许多人小时候的疫苗接种经历。“口味香甜,价格低廉,服用方便”给很多人留下了印象。然而,大家或许并不知道,“小糖丸”的诞生十分艰难,它是伴随着我国与脊髓灰质炎抗争的过程,逐渐研制出来的。20世纪50年代初,新中国刚刚建立,国内部分省区就爆发了脊髓灰质炎,俗称小儿麻痹症。脊髓灰质炎是一种严重危害健康的传染病,也是WHO(世界卫生组织)计划继天花后第二个要消灭的传染病。据中国医学科学院医学生物研究所相关负责 “Little candy ” is a lot of childhood vaccination experience. “Taste sweet, cheap, easy to take ” to many people left an impression. However, we may not know that the birth of “Candy” is very difficult. It was gradually developed along with the process of our country’s fight against poliomyelitis. In the early 1950s, when New China was just established, poliomyelitis broke out in some provinces and regions in China, commonly known as polio. Poliomyelitis is a serious health-related infectious disease and is the second World Health Organization (WHO) plan to eradicate as a second infectious disease. According to the Chinese Academy of Medical Sciences Institute of Medical Biology related responsible